SEC Form 4 · accession 0001445064-15-000157
Keenova Therapeutics plc
Statement of changes in beneficial ownership, as filed. Original on EDGAR ↗
Reporting owner
Gary M. Phillips
Officer — Sr. VP, Chief Strategy Officer
Period of report
Dec 2, 2015
Accepted (ET)
Dec 3, 2015 · 9:03 am EST
Rule 10b5-1 plan
unknown — predates the checkbox
Issuer CIK
0001567892
Table I — non-derivative securities
| Security | Date | Code | Shares | Price | A/D | Owned after | D/I | Nature of ownership |
|---|---|---|---|---|---|---|---|---|
| Ordinary SharesF1 | Dec 2, 2015 | P | 500 | $71.57 | A | 7,228 | D | |
| Ordinary SharesF2 | Dec 2, 2015 | P | 500 | $72.76 | A | 7,728 | D |
Table II — derivative securities
No Table II lines on this filing.
Explanation of responses
- F1The price represents a weighted average. The shares were purchased in multiple transactions at prices ranging from $71.36 to $71.78 inclusive. Mr. Phillips will provide, upon request of the SEC staff, Mallinckrodt plc or a shareholder of Mallinckrodt plc complete information regarding the number of shares purchased at each price within the range.
- F2The price represents a weighted average. The shares were purchased in multiple transactions at prices ranging from $72.68 to $72.81 inclusive. Mr. Phillips will provide, upon request of the SEC staff, Mallinckrodt plc or a shareholder of Mallinckrodt plc complete information regarding the number of shares purchased at each price within the range.